Exact Mass: 304.1827
Exact Mass Matches: 304.1827
Found 113 metabolites which its exact mass value is equals to given mass value 304.1827,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
8-Cyclopentyl-1,3-dipropylxanthine
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists DPCPX (PD 116948), a xanthine derivative, is a highly potent and selective Adenosine A1 receptor antagonist, with a Ki of 0.46 nM in 3H-CHA binding to A1 receptors in rat whole brain membranes[1][2][3].
3-Methyladipoylcarnitine
3-Methyladipoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyladipoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-methyladipoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). 3-Methyladipoylcarnitine has been identified in blood and urine (PMID: 31396400 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3,9-Bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane
(1alpha,4beta,5beta,6beta,7beta,9alpha,10alpha)-1,4,6,9,15-Eudesmanepentol
(Z)-docos-19-ene-2,9,11,13,21-pentayn-1-ol|Siphonochalynol
ascr#10
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (8R)-8-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). A metabolite of the nematode Caenorhabditis elegans, it is the direct biosynthetic precursor to ascr#3. It has also been detected in the sour paste nematode, Panagrellus redivivus.
oscr#10
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
2-ETHYLHEXYL α-CYANO-4-(3-METHYLOXAZOLIN-2-YLIDENE)CROTONATE
ISOPROPYL 3-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
methyl 4-(3-piperidin-1-ylpropylcarbamoyl)benzoate
(R)-tert-Butyl 4-benzyl-2-formylpiperazine-1-carboxylate
4-[2-(HydroxyMethyl)-1H-benzoimidazol-1-yl]butyl Pivalate
Tilisolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
2-(1,3-Dioxolan-2-yl)-1-phenylethylboronic acid pinacol ester
Boronic acid, [1-[(1,1-dimethylethyl)dimethylsilyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-, dimethyl ester (9CI)
4,4,5,5-TETRAMETHYL-2-(4-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE
1-methyl-4-[1-(4-nitrophenyl)piperidin-4-yl]piperazine
Ethyl 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate
4-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester
TERT-BUTYL 4-(4-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE
tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
4,4,5,5-TETRAMETHYL-2-(3-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE
3-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester
Tracazolate
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
TERT-BUTYL 4-(3-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE
2,2-(2,4,8,10-TETRAOXASPIRO[5.5]UNDECANE-3,9-DIYL)BIS(2-METHYLPROPAN-1-OL)
Methylatropine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid
(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid
(3-endo)-3-[(2S)-3-Hydroxy-1-oxo-2-phenylpropoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane
2-Acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide
[(2R)-3-carboxy-2-[(3S)-5-carboxy-3-methylpentanoyl]oxypropyl]-trimethylazanium
[3-Carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium
[(2R)-3-carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(4-carboxy-4-methylpentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(4-carboxyhexanoyloxy)propyl]-trimethylazanium
Indolo(2,3:3,4)pyrido(1,2-b)(2,7)naphthyridinium, 5,7,8,13,13b,14-hexahydro-5,6-dimethyl-, (5S,6R,13bS)-
3-hydroxy-2-phenylpropanoic acid [(5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester
(2S)-3-methyl-2-[[oxo-(1,2,3,4-tetrahydronaphthalen-1-ylamino)methyl]amino]pentanoic acid
[(1S)-3-carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium
DPCPX
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists DPCPX (PD 116948), a xanthine derivative, is a highly potent and selective Adenosine A1 receptor antagonist, with a Ki of 0.46 nM in 3H-CHA binding to A1 receptors in rat whole brain membranes[1][2][3].
(4e,13e,19e)-docosa-4,13,19-trien-2,9,11,21-tetrayn-1-ol
3,3'-bis(indolylmethyl)dimethylammonium
{"Ingredient_id": "HBIN007159","Ingredient_name": "3,3'-bis(indolylmethyl)dimethylammonium","Alias": "NA","Ingredient_formula": "C20H22N3(+)","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8362","PubChem_id": "NA","DrugBank_id": "NA"}
